Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 3/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.35 |
| ▸ | RXRB | P28702 | 1/20 | 0.35 |
| ▸ | RXRG | P48443 | 1/20 | 0.35 |
| ▸ | DDB1 | Q16531 | 3/20 | 0.35 |
| ▸ | CRBN | Q96SW2 | 3/20 | 0.35 |
| ▸ | TLR2 | O60603 | 2/20 | 0.33 |
| ▸ | TLR1 | Q15399 | 2/20 | 0.33 |
| ▸ | BRD4 | O60885 | 2/20 | 0.33 |
| ▸ | FPR3 | P25089 | 2/20 | 0.33 |
| ▸ | FPR2 | P25090 | 2/20 | 0.33 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.32 |
| ▸ | KRAS | P01116 | 1/20 | 0.32 |
| ▸ | PLK1 | P53350 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30869153 | 0.90 | ATR (0.41) | ATRRXRARXRBRXRGDDB1 | |
| SCHEMBL30869070 | 0.87 | ATR (0.42) | ATRRXRARXRBRXRGDDB1 | |
| SCHEMBL30869074 | 0.86 | ATR (0.43) | ATRRXRARXRBRXRGTLR2 | |
| SCHEMBL30797730 | 0.86 | ATR (0.44) | ATRRXRARXRBRXRGDDB1 | |
| SCHEMBL30869078 | 0.84 | ATR (0.45) | ATRDDB1CRBNTLR2TLR1 | |
| SCHEMBL30797851 | 0.84 | ATR (0.43) | ATRRXRARXRBRXRGDDB1 | |
| SCHEMBL30869032 | 0.83 | ATR (0.42) | ATRRXRARXRBRXRGDDB1 | |
| SCHEMBL30797547 | 0.82 | ATR (0.42) | ATRRXRARXRBRXRGTLR2 | |
| SCHEMBL30797688 | 0.82 | ATR (0.44) | ATRRXRARXRBRXRGDDB1 | |
| SCHEMBL27376667 | 0.82 | ATR (0.41) | ATRRXRARXRBRXRGDDB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4584249-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | Cambridge Enterprise Limited (GB) | 2025-07-16 | — | — | EP | disclosed |
| WO-2024052702-A1 | NOVEL COMPOUNDS AS CK2 INHIBITORS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2024-03-14 | — | — | WO | disclosed |